Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Urogen Pharma Ltd. (URGN)  
$13.27 0.36 (2.79%) as of 4:30 Tue 5/21


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 22,090,000
Market Cap: 293.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $8.84 - $22.64
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   roGen Pharma is a biopharmaceutical company focused on developing and commercializing solutions that treat urothelial and specialty cancers. Co.'s approved product Jelmyto® (mitomycin) for pyelocalyceal solution, and its investigational candidate, UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer, respectively. In addition, Co.'s immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,000 29,564 33,364 41,023
Total Sell Value $168,600 $445,409 $513,847 $580,710
Total People Sold 1 2 2 2
Total Sell Transactions 1 5 6 11
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 156
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-12-04 4 OE $0.00 $0 D/D 1,042 20,385     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-12-03 4/A OE $0.00 $0 D/D 8,808 219,117     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-11-03 4/A OE $0.00 $0 D/D 8,808 210,309     -
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-10-26 4 S $20.95 $2,116 D/D (101) 19,343 9%     
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-10-26 4 OE $0.00 $0 D/D 208 19,444     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-10-15 4 S $21.72 $52,248 D/D (2,400) 10,405 11%     
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-10-15 4 OE $0.00 $0 D/D 4,917 12,805     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-10-03 4/A OE $0.00 $0 D/D 8,808 201,501     -
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-09-04 4 S $20.20 $7,030 D/D (348) 19,236 1%     
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-09-04 4 OE $0.00 $0 D/D 1,041 19,584     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-09-03 4/A OE $0.00 $0 D/D 8,807 192,693     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-09-01 4 S $22.82 $11,615 D/D (509) 7,888 5%     
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-09-01 4 OE $0.00 $0 D/D 1,042 8,397     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-08-03 4/A OE $0.00 $0 D/D 8,807 183,886     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-07-27 4 S $23.51 $3,315 D/D (141) 7,355 20%     
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-07-27 4 S $23.51 $1,646 D/D (70) 18,543 20%     
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-07-26 4 OE $0.00 $0 D/D 417 7,496     -
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-07-26 4 OE $0.00 $0 D/D 209 18,613     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-07-03 4/A OE $0.00 $0 D/D 8,807 175,079     -
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-06-04 4 S $27.51 $9,602 D/D (349) 18,404 14%     
   Schoenberg Mark Chief Medical Officer   •       –      –    2020-06-04 4 OE $0.00 $0 D/D 1,042 18,753     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-06-03 4/A OE $0.00 $0 D/D 8,807 166,272     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-05-20 4 S $25.07 $8,975 D/D (358) 7,079 21%     
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2020-05-20 4 OE $0.00 $0 D/D 1,041 7,437     -
   Barrett Elizabeth A. Chief Executive Officer   •       –      –    2020-05-12 4 OE $0.00 $0 D/D 35,229 157,465     -
  156 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us